The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026. Opioids are drugs that stimulate the brain to produce a variety of effects, including pain relief.
The term opioid refers to all substances (exogenous or endogenous) that possess morphine-like properties. Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and to treat severe constant pain in patients who suffer from terminal illnesses.
The growth of the global opioids market is driven by alarming increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and surge in global geriatric population are expected to propel the growth of the global opioids market.
However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.
The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment. The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
ü The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
ü It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
ü Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
ü Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product Type
• Codeine
• Fentanyl
• Methadone
• Oxycodone
• Morphine
• Hydrocodone
By Application
• Pain Management
• Cough Treatment
• Diarrhea Treatment
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Spain
o Russia
o Rest of Europe
• Asia-Pacific
o China
o Japan
o India
o Australis
o South Korea
o Taiwan
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Purdue Pharma
• Boehringer Ingelheim
• Janssen Pharmaceuticals, Inc.
• Sanofi
• Sun Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Endo Pharmaceuticals Inc.
• Allergan, Plc
• Pfizer, Inc.
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase Use of Opioids In Pain Management
3.4.1.2. Upsurge In Consumption of Opioids In Developing Economies
3.4.2. Restraints
3.4.2.1. Implementation of Stringent Government Regulation Toward Vigorous Prescription
3.4.2.2. Opioid Crisis Across The Globe
3.4.3. Impacting Factors
Chapter 4: Opioids Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast, By Product Type
4.2. Codeine
4.2.1. Key Market Trends
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Fentanyl
4.3.1. Key Market Trends
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Oxycodone
4.4.1. Key Market Trends
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5. Methadone
4.5.1. Key Market Trends
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6. Morphine
4.6.1. Key Market Trends
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7. Hydrocodone
4.7.1. Key Market Trends
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8. Others
4.8.1. Key Market Trends
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
Chapter 5: Opioids Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast, By Application
5.2. Pain Management
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.2.2.1. Neuropathic Pain
5.2.2.1.1. Market Size And Forecast
5.2.2.2. Migraine
5.2.2.2.1. Market Size And Forecast
5.2.2.3. Back Pain
5.2.2.3.1. Market Size And Forecast
5.2.2.4. Osteoarthritis Pain
5.2.2.4.1. Market Size And Forecast
5.2.2.5. Cancer Pain
5.2.2.5.1. Market Size And Forecast
5.2.2.6. Others
5.2.2.6.1. Market Size And Forecast
5.3. Cough Treatment
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Diarrhea Treatment
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
Chapter 6: Opioids Market, By Region
6.1. Overview
6.1.1. Market Size And Forecast
6.2. North America
6.2.1. Key Market Trends
6.2.2. Market Size And Forecast, By Product
6.2.3. Market Size And Forecast, By Application
6.2.4. Market Size And Forecast, By Country
6.2.4.1. U.S. Market Size And Forecast, By Product
6.2.4.2. U.S. Market Size And Forecast, By Application
6.2.4.3. Canada Market Size And Forecast, By Product
6.2.4.4. Canada Market Size And Forecast, By Application
6.2.4.5. Mexico Market Size And Forecast, By Product
6.2.4.6. Mexico Market Size And Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends
6.3.2. Market Size And Forecast, By Product
6.3.3. Market Size And Forecast, By Application
6.3.4. Market Size And Forecast, By Country
6.3.4.1. France Market Size And Forecast, By Product
6.3.4.2. France Market Size And Forecast, By Application
6.3.4.3. Uk Market Size And Forecast, By Product
6.3.4.4. Uk Market Size And Forecast, By Application
6.3.4.5. Germany Market Size And Forecast, By Product
6.3.4.6. Germany Market Size And Forecast, By Application
6.3.4.7. Spain Market Size And Forecast, By Product
6.3.4.8. Spain Market Size And Forecast, By Application
6.3.4.9. Rest of Europe Market Size And Forecast, By Product
6.3.4.10. Rest of Europe Market Size And Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends
6.4.2. Market Size And Forecast, By Product
6.4.3. Market Size And Forecast, By Application
6.4.4. Market Size And Forecast, By Country
6.4.4.1. Japan Market Size And Forecast, By Product
6.4.4.2. Japan Market Size And Forecast, By Application
6.4.4.3. China Market Size And Forecast, By Product
6.4.4.4. China Market Size And Forecast, By Application
6.4.4.5. India Market Size And Forecast, By Product
6.4.4.6. India Market Size And Forecast, By Application
6.4.4.7. Australia Market Size And Forecast, By Product
6.4.4.8. Australia Market Size And Forecast, By Application
6.4.4.9. Taiwan Market Size And Forecast, By Product
6.4.4.10. Taiwan Market Size And Forecast, By Application
6.4.4.11. South Korea Market Size And Forecast, By Product
6.4.4.12. South Korea Market Size And Forecast, By Application
6.4.4.13. Rest of Asia-Pacific Market Size And Forecast, By Product
6.4.4.14. Rest of Asia-Pacific Market Size And Forecast, By Application
6.5. Lamea
6.5.1. Key Market Trends
6.5.2. Market Size And Forecast, By Product
6.5.3. Market Size And Forecast, By Application
6.5.4. Market Size And Forecast, By Country
6.5.4.1. Brazil Market Size And Forecast, By Product
6.5.4.2. Brazil Market Size And Forecast, By Application
6.5.4.3. Turkey Market Size And Forecast, By Product
6.5.4.4. Turkey Market Size And Forecast, By Application
6.5.4.5. Saudi Arabia Market Size And Forecast, By Product
6.5.4.6. Saudi Arabia Market Size And Forecast, By Application
6.5.4.7. South Africa Market Size And Forecast, By Product
6.5.4.8. South Africa Market Size And Forecast, By Application
6.5.4.9. Rest of Lamea Market Size And Forecast, By Product
6.5.4.10. Rest of Lamea Market Size And Forecast, By Application
Chapter 7: Compony Profiles
7.1. Allergan Plc.
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.1.5. Business Performance
7.2. Boehringer Ingelheim Group
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.2.5. Business Performance
7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Johnson & Johnson (Janssen Global Services, Llc)
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.4.5. Business Performance
7.5. Mallinckrodt Plc (Specgx Llc)
7.5.1. Company Overview
7.5.2. Company Snapshot
7.5.3. Operating Business Segments
7.5.4. Product Portfolio
7.5.5. Business Performance
7.6. Pfizer Inc.
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Purdue Pharma L.P.
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.7.5. Business Performance
7.8. Sanofi S.A.
7.8.1. Company Overview
7.8.2. Company Snapshot
7.8.3. Operating Business Segments
7.8.4. Product Portfolio
7.8.5. Business Performance
7.9. Sun Pharmaceutical Industries Ltd.
7.9.1. Company Overview
7.9.2. Company Snapshot
7.9.3. Operating Business Segments
7.9.4. Product Portfolio
7.9.5. Business Performance
7.10. Teva Pharmaceutical Industries Limited
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance